echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > China has entered the era of "active prevention" of cytomegalovirus, and it is expected that innovative drugs will benefit more patients

    China has entered the era of "active prevention" of cytomegalovirus, and it is expected that innovative drugs will benefit more patients

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 29, the National Medical Security Bureau issued the Announcement


    However, in some relatively "unpopular" disease areas, there are still many unmet treatment needs, and the prevention and control of cytomegalovirus infection is one of


    A new preventative option

    As a major innovative drug in the field of cytomegalovirus prevention and control, the new non-nucleoside cytomegalovirus inhibitor Letmovir tablets and letamovir injection have been approved to enter China


    Data from key phase III clinical trials of letamovir showed that the clinically significant CMV infection rate and all-cause mortality rate at 24 weeks after transplantation were significantly reduced


    Innovations are in the spotlight

    This breakthrough innovation has also attracted the attention


    With the continuous acceleration of the construction of "Healthy China 2030", medical innovation will provide strong support


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.